Over the forecast period, the global market for complete blood count devices is anticipated to rise at a faster rate due to the rising prevalence of blood infections. For instance, sepsis claims the lives of 11 million people worldwide each year, according to a World Health Organisation report released in September 2020. In addition, sepsis develops when chemicals sent through the bloodstream to treat an infection cause inflammation all across the body. The demand for white blood cell count (WBC or leukocyte count) tests is therefore anticipated to rise as the prevalence of serious blood infections rises. Over the forecast period, product releases by major market players are anticipated to fuel market expansion. A tabletop haematology analyzer called DxH 560 AL, for instance, was introduced by the medical technology business Beckman Coulter in February 2021. It was created to help small to mid-sized diagnostic laboratories with their resource and time restrictions. The DxH 560 AL also produces findings in no more than 60 seconds.
According to Coherent Market Insights, over the projected period (2021-2028), the market for Complete Blood Count Devices is anticipated to grow at a CAGR of 8.3%, reaching an estimated value of US$ 3,642.9 million in 2021.
Market Players in the Complete Blood Count Device Industry:
1. Abbott Laboratories
The company was established in 1888, and its US headquarters are in Chicago, Illinois. It sells wholesome products, name-brand generic drugs, medical equipment, and diagnostics. In January 2022, Abbott revealed the Lingo collection of consumer biowearable sensors. To optimise food and exercise regimens, Lingo collects a range of biological measures. Proclaim Plus from Abbott, a multipurpose spinal cord stimulation device for treating chronic pain, received FDA approval in August 2022.
2. Becton, Dickinson and Company
The company was established in 1897 and has its headquarters in New Jersey, U.S. The business produces and markets reagents, instrument systems, and medical equipment. Moreover, BD offers analytics and consulting services in some areas. BD receives FDA 510(k) clearance in March 2023 for the first-ever high-throughput diagnostic test for infectious vaginitis. BD will launch a High-Throughput Single-Cell Multiomics Platform in February 2023 to broaden the scope of scientific discovery.
3. Danaher Corporation
The company was created in 1969 and has its headquarters in Washington, D.C., United States. The business creates, produces, and sells goods and services for the medical, industrial, and commercial industries. The biopharma branch of General Electric Life Sciences was purchased by Danaher in March 2020 for $21.4 billion and renamed Cytiva.
4. Siemens Healthineers
It was established in 1847 and has its main office in Erlangen, Germany. The business acts as a provider of medical technology, specialising in medical imaging, laboratory diagnostics, point-of-care testing, digital ecosystems, and reading solutions for use in the healthcare industry. The company declared its intention to purchase Varian Medical Systems in August 2020.
5. Bio-Rad Laboratories, Inc.
The company was started in 1952 and has its headquarters in California, United States. The business creates and manufactures specialised technology devices for the markets of clinical diagnostics and life science research. In March 2021, Bio-Rad and Roche officially announced their partnership. The business has a deal to buy all of Curiosity Diagnostics' outstanding shares in August 2022.
6. PerkinElmer, Inc.
The firm was founded in 1937 and has its headquarters in Massachusetts, United States. The business is primarily focused on tests related to diagnostics, life sciences, food, the environment, and industry. Information technology, scans, identification, and service are among its strengths. PerkinElmer concluded the divestiture of its applied, food, and enterprise services businesses in March 2023.
7. Nihon Kohden Corporation
The company was started in 1951 and has its main office in Tokyo, Japan. The business creates, produces, and markets transformers, power switches, and medical equipment. The company produces biogenic monitoring systems, systems for circulation, medical devices, electroencephalographs, and testing tools for the cerebral nerve.
*Definition: The complete blood count (CBC) equipment is frequently used as part of a medical evaluation to screen for illnesses. It is helpful for calculating the levels of platelets, red and white blood cells, haemoglobin, and hematocrit.
